The Functional Evaluation of Dendritic Cell Vaccines Based on Different Hepatitis C Virus Nonstructural Genes

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Viral immunology

• Publication date

  2007-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/vim.2007.0064PMID 18158729
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.

  2007cited by this paper
• Induction of Antigen-Specific Immune Responses in Vivo After Vaccination with Dendritic Cells Transduced with Adenoviral Vectors Encoding Hepatitis C Virus NS3

  2006cited by this paper
• Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities.

  2006cited by this paper
• T cell response in hepatitis C virus infection.

  2005cited by this paper
• Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes.

  2004cited by this paper
• Lack of Phenotypic and Functional Impairment in Dendritic Cells from Chimpanzees Chronically Infected with Hepatitis C Virus

  2004cited by this paper
• Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.

  2004cited by this paper
• CD8 Epitope Escape and Reversion in Acute HCV Infection

  2004cited by this paper
• Cell-mediated immunity and the outcome of hepatitis C virus infection.

  2004cited by this paper
• Memory T cells and vaccines.

  2003cited by this paper
• Hepatitis C virus–like particles combined with novel adjuvant systems enhance virus‐specific immune responses

  2003cited by this paper
• DNA Immunization with Hepatitis C Virus (HCV) Polycistronic Genes or Immunization by HCV DNA Priming-Recombinant Canarypox Virus Boosting Induces Immune Responses and Protection from Recombinant HCV-Vaccinia Virus Infection in HLA-A2.1-Transgenic Mice

  2003cited by this paper
• Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo

  2003cited by this paper
• The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity

  2003cited by this paper
• Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

  2003cited by this paper
• Heterogeneity of CD4(+) and CD8(+) T cells.

  2003cited by this paper
• Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins

  2002cited by this paper
• Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities

  2002cited by this paper
• Cellular immune responses against hepatitis C virus: the evidence base 2002

  2002cited by this paper
• A truncated HCV core protein elicits a potent immune response with a strong participation of cellular immunity components in mice.

  2001cited by this paper
• Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

  2001cited by this paper
• Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

  2000cited by this paper
• Hepatitis C epidemiology.

  2000cited by this paper
• DNA Vaccination:  Transfection and Activation of Dendritic Cells as Key Events for Immunity

  1999cited by this paper
• Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

  1999cited by this paper
• Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization.

  1999cited by this paper
• Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo.

  1998cited by this paper
• Recurrence of hepatitis C virus after loss of virus specific CD4+ T cell response in acute hepatitis C

  1998cited by this paper
• Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection.

  1996cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper

• Research progress on the role of dendritic cells in glioma during 1992-2024: a bibliometric analysis

  2025cites this paper
• In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?

  2021cites this paper
• Immunotherapy and Vaccine Development in Viral Hepatitis

  2013cites this paper
• DCs Pulsed with Novel HLA-A2-Restricted CTL Epitopes against Hepatitis C Virus Induced a Broadly Reactive Anti-HCV-Specific T Lymphocyte Response

  2012cites this paper
• Generation of functional monocyte-derived fast dendritic cells suitable for clinical application in the absence of interleukin-6

  2011cites this paper
• Prediction and identification‐based prediction of Chinese hepatitis C viral‐specific cytotoxic T lymphocyte epitopes

  2011cites this paper
• T-Cell-Mediated Immunity and Immunotherapy of Chronic Hepatitis C

  2009cites this paper
• When to treat and the benefits of treating hepatitis C in patients with haemophilia

  2009cites this paper
• Recombinant adenoviral nanostructures: Construction and prospects of use in medicine

  2009cites this paper
• Distinctive pattern of sequence polymorphism in the NS3 protein of hepatitis C virus type 1b reflects conflicting evolutionary pressures.

  2008cites this paper